#hsct search results

"The DKMS Access to Transplantation program: addressing barriers to HSCT." Read the full article in Blood Global Hematology: ow.ly/eFoH50YO15U #HSCT

#goedemorgen.. Dit kreeg ik van mijn meisje ❤️😭 Niet te doen.. Ik hoop nog steeds dat de #hsct gaat lukken..🤞🏻 Al staat de mygofundme stil.. Dit breekt mijn hart! #ms #gezondheid

Steroid-refractory aGVHD Expansion of activated CD28⁺ CD8⁺ Tem cells predicts steroid resistance. STAT1–glucocorticoid receptor axis drives resistance → JAK inhibition may reverse it. #GVHD #HSCT #Immunology #Transplant #Ruxolitinib @Satyayadav__ ashpublications.org/blood/article-…

Fecal microbiota transplantation (FMT) promising strategy for GI complications post allo-HSCT — targeting dysbiosis, infections & GVHD. Still, heterogeneity in protocols & outcomes highlights need for standardization. #HSCT #FMT #GVHD astctjournal.org/article/S2666-… @Satyayadav__

#Maribavir for csCMVi in #HSCT: a real-world retrospective international study of the IDWP of @TheEBMT @md_annalisapavi #ESCMIDGlobal2026 @ESCMID Great results, mild AEs, excellent tolerance and CMV clearance rates… even in 1L

#ESCMIDGlobal2026 Fully crowded room for #CMV after SOT and #HSCT @ESCMID

#ESCMID26 Lukas Jeker @UniBasel_en amazing presentation using CD45 modified cells to treat Hematological malignancies and potentially infectious diseases someday! #HSCT #HematoInfecto

🍎🥦 Timely referral to a dietitian with #oncology expertise is ‘an imperative step’ for #HSCT recipients, per new guidelines in @ASTCT_Journal. This can mitigate #WeightLoss and reduce risk for #malnutrition. vist.ly/4ypix

#goedemorgen.. Eigenlijk wil ik de dom nog een keer beklimmen.. maar of mijn benen dat nog trekken 😔. Mijn GFM staat helaas stil, blijf hoop houden dat het gaat lukken. gofund.me/e37e7be4b #ms #hsct #hoop

Age shouldn't limit life-saving care. We've successfully performed stem cell transplants for leukemia & lymphoma patients up to 76 years old. Tailored regimens + expert MDT support = new hope for elderly patients. 🎥👇 #HSCT #Leukemia

Using single-cell RNA-seq, Manabu Wakamatsu, Megumu Saito @CiRA_KU_E, Hideki Muramatsu @NagoyaUniv & colleagues show that rhG-CSF suppresses IFNγ signaling and promotes B-cell differentiation in reticular dysgenesis, with potential benefits before #HSCT. hubs.la/Q049Jh6g0

Findings support including B-leader status in haploidentical donor selection in Latin America. Read in Blood Global Hematology: ow.ly/fcbF50Yz8vJ #LatinAmerica #HSCT #GVHD

🛎️The #Topic "Outcomes of Hematopoietic Stem Cell Transplantation in Patients with Leukemia" is open for submissions! #HSCT #leukemia @MDPIOpenAccess ⏳Abstract submission: 31 October 2026 ⌛️Manuscript submission: 31 December 2026 👉More information at: shorturl.at/qnHof

At EBMT 2026 in Madrid, a powerful message has resonated across sessions: Donors matter! HLA disparity is no longer a barrier—it’s becoming a tool for patients whose only curative option remains hematopoietic stem cell transplantation. #EBMT2026 #DonorsMatter #HSCT #HLA

Zelf zit ik bijna op de helft van mijn crowdfunding en is het de vraag of ik het haal . De behandeling staat gepland voor 28 september.. 🤞🏻🤞🏻🤞🏻 hoop doet leven! Enormdankbaar als dit gaat lukken #ms #rtlnieuws #hsct gofund.me/444df0079

Good job from our department #HSCT #CART at @HospiLaPaz presented in #Madrid for the 52nd Annual Meeting of the @TheEBMT #EBMT26

So thankful of my team and dear friends from #HSCT #immunology #CART at @GOSHCharity @GreatOrmondSt and all my #UK colleagues who help us to run this TA-TMA study presented in #Madrid for the 52nd Annual Meeting of the @TheEBMT #EBMT26 @GETH_info

Tuberculosis, 144 years later… still relevant in HSCT. Reactivation, atypical presentation, and complex management remain key challenges. #HSCT #Tuberculosis #Hematology

Pos HSCT and ICU (Poster B134) 🩸 -Mexico City – 16y (2009-2025) -1178 Px🙋 - ASCT n=600 and Allo-SCT n=578 -Principal Dx Acute Leukemia …. Low admission rate, but high mortality among those requiring ICU #EBMT26 #poster #hsct

Excellent session on donor selection and germline mutations. An important and evolving challenge in allogeneic transplantation, highlighting how inherited predisposition may significantly influence donor choice and long-term outcomes. #EBMT2026 #HSCT #Hematology

"The DKMS Access to Transplantation program: addressing barriers to HSCT." Read the full article in Blood Global Hematology: ow.ly/eFoH50YO15U #HSCT

📢 Second Allo-HSCT (HSCT2): A lifeline for relapsed patients? 🚨 For relapses >6 months post-HSCT1. ✅ Requirements: Achieved CR post-salvage with no prior high-grade GVHD. 📈 Better outcomes in younger patients. 🤔 Donor: Same vs different = similar results #HSCT #ASH24

Findings support including B-leader status in haploidentical donor selection in Latin America. Read in Blood Global Hematology: ow.ly/fcbF50Yz8vJ #LatinAmerica #HSCT #GVHD

HSCT yields satisfactory long-term outcomes in patients with PNP deficiency. OS was best in early-diagnosed patients without neurologic symptoms. Read in Blood: ow.ly/6B6v50XTGuZ #HSCT #BloodJournal

CONGRESS #EHA2023 | Philipp Berning @UK_Muenster presents a retrospective analysis on role of allo #HSCT in 135 pts with R/R NK T-cell #lymphoma. 5-yr PFS & OS were 48.6% & 52.9%, respectively. 3-yr NRM was 17.3%. MAC & RIC regimens showed similar survival. #lym #lymsm

The incidence of short-term CV events in #HSCT recipients is relatively low. Long-term events were more common among allogeneic recipients and those with pre-existing CV comorbidities. Learn more: bit.ly/47ydN6G #JACCCardioOnc #CardioOnc #BMTsm #CVD @salimhayek

🧬📊 CMV Preemptive Therapy in HSCT Weekly CMV PCR from Day 0 ➜ treat when: • High-risk: >150 IU/mL • Low-risk: >500–1000 IU/mL ⚠️ ANC >1×10⁹/L → Valganciclovir 💊 ANC <1×10⁹/L → Foscarnet 💧 Reassess after 2 weeks: clear, decline, or rising → adjust therapy 🔄 #HSCT #CMV

New in #JACCCardioOnc: After hematopoietic stem cell transplant #HSCT, ~1 in 4 patients developed #POTS, and it was linked to: 🔹Exaggerated norepinephrine rise on standing 🔹Higher adrenergic receptor-modulating autoantibody activity 📖: jacc.org/doi/abs/10.101… @AbbateAntonio

💉 Allogeneic #HSCT is still needed for many children with very high-risk acute #leukemia. This study introduces a novel HLA-haploidentical HSCT strategy with very promising outcomes in #pediatric patients! Sounds interesting? 👉 go.nature.com/3koWkv1

🆕 Exciting advancement in #MDS treatment! An international team, including Dr @SoleKiko and Dr Blanca Xicoy from #IJC, has developed a new tool to optimize #HSCT timing. Check out more about the study, published in @JCO_ASCO, here 👇 carrerasresearch.org/en/news/new-to…

👇 Pro tip for #IDWeek2024. No FOMO. No FOMO. No FOMO. 🍽️ Exclusive Educational Dinner: Dr. Roy Chemaly will present his latest research on #CMV T cell immunity in #HSCT recipients at the renowned Mastro's Ocean Club. @ChemalyRoy #ChemalyTeam 👉 Did we mention #NoFOMO? 🗓️

#HSCT recipients who received at least one dose of #COVID19 vaccine reported no or minimal adverse effects and were less likely to contract COVID-19, according to findings presented by Fred Hutch hematology/oncology fellow @emilyliangmd at #ASH22. bit.ly/3VIrtWQ

🧬 #Kidney injury after #HSCT is multifactorial—but a structured approach saves kidneys From #AKI ➡️ #TMA ➡️ #GN ➡️ #CKD, early recognition + targeted therapy is everything 📊Excellent flowchart for clinicians managing post-HSCT renal complications 🔗doi.org/10.1093/ndt/gf… 🆕

Nabelschnurblutspenden in Deutschland rückläufig, Relevanz könnte zunehmen: Dresden/Düsseldorf – Im Gegensatz zu anderen europäischen Ländern spielen hämatopoetische Stammzellen aus Nabelschnurblut, dem Restblut aus der Plazenta,… dlvr.it/T10grk #DKMS #ZKRD #HSCT

Efficacy and safety of autologous haematopoietic stem cell transplantation #HSCT for aggressive #MultipleSclerosis Review from @giackbo @unige_en @RaffaellaGrecoM @SanRaffaeleMI on the behalf of @TheEBMT ▶️ journals.sagepub.com/doi/abs/10.117…

#EBMT25 Outstanding presentation @GenPapaMD @MSKCancerCenter Impact of CMV Reactivation/Disease is huge in our #HSCT patients! We must improve our prophylactic practices and monitoring viral loads on the PTCy era!

Interested in HSCT for #MS? Our blogger Natalie reviewed Selma's documentary about her stem cell journey. Read more about 'Introducing, Selma' and find out about HSCT trial StarMS: mssoc.uk/3ovwVBA #MultipleScleroris #HSCT #STARMS

Congrats to Fred Hutch #HSCT pioneer Dr. Rainer Storb on receiving the Wallace H. Coulter Award for Lifetime Achievement in Hematology at #ASH25! 🩸 👉 bit.ly/3MkdPdx

Algorithm for treating #VEXAS (confirmed by genetics)!!! 🔴 Target infiammation using glicocorticoids and steroid sparing agent (JAKi better) 🔵Target hematologic policlonality considering #HSCT OR azacitidine #EULAR2025 @eular_ARD

Fred Hutch at #ASH25: Don't miss #HSCT pioneer Dr. Rainer Storb receive the Wallace H. Coulter Award for Lifetime Achievement in Hematology! 🩸 👉 bit.ly/3MkdPdx